vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.

READING INTERNATIONAL INC is the larger business by last-quarter revenue ($50.3M vs $26.6M, roughly 1.9× NeuroPace Inc). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -10.3%, a 5.2% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $409.0K). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs 5.6%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.

NPCE vs RDI — Head-to-Head

Bigger by revenue
RDI
RDI
1.9× larger
RDI
$50.3M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+38.0% gap
NPCE
23.9%
-14.2%
RDI
Higher net margin
RDI
RDI
5.2% more per $
RDI
-5.1%
-10.3%
NPCE
More free cash flow
RDI
RDI
$3.7M more FCF
RDI
$4.1M
$409.0K
NPCE
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
5.6%
RDI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
RDI
RDI
Revenue
$26.6M
$50.3M
Net Profit
$-2.7M
$-2.6M
Gross Margin
77.4%
Operating Margin
-6.6%
-1.9%
Net Margin
-10.3%
-5.1%
Revenue YoY
23.9%
-14.2%
Net Profit YoY
48.0%
-14.5%
EPS (diluted)
$-0.08
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
RDI
RDI
Q4 25
$26.6M
$50.3M
Q3 25
$27.4M
$52.2M
Q2 25
$23.5M
$60.4M
Q1 25
$22.5M
$40.2M
Q4 24
$21.5M
$58.6M
Q3 24
$21.1M
$60.1M
Q2 24
$19.3M
$46.8M
Q1 24
$18.1M
$45.1M
Net Profit
NPCE
NPCE
RDI
RDI
Q4 25
$-2.7M
$-2.6M
Q3 25
$-3.5M
$-4.2M
Q2 25
$-8.7M
$-2.7M
Q1 25
$-6.6M
$-4.8M
Q4 24
$-5.3M
$-2.2M
Q3 24
$-5.5M
$-7.0M
Q2 24
$-7.5M
$-12.8M
Q1 24
$-8.9M
$-13.2M
Gross Margin
NPCE
NPCE
RDI
RDI
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
RDI
RDI
Q4 25
-6.6%
-1.9%
Q3 25
-9.5%
-0.6%
Q2 25
-29.0%
4.8%
Q1 25
-22.9%
-17.2%
Q4 24
-17.0%
2.6%
Q3 24
-20.1%
-0.6%
Q2 24
-32.4%
-16.4%
Q1 24
-41.6%
-16.7%
Net Margin
NPCE
NPCE
RDI
RDI
Q4 25
-10.3%
-5.1%
Q3 25
-12.8%
-8.0%
Q2 25
-36.8%
-4.4%
Q1 25
-29.3%
-11.8%
Q4 24
-24.5%
-3.8%
Q3 24
-25.9%
-11.7%
Q2 24
-39.0%
-27.4%
Q1 24
-49.2%
-29.4%
EPS (diluted)
NPCE
NPCE
RDI
RDI
Q4 25
$-0.08
$-0.11
Q3 25
$-0.11
$-0.18
Q2 25
$-0.26
$-0.12
Q1 25
$-0.21
$-0.21
Q4 24
$-0.16
$-0.11
Q3 24
$-0.19
$-0.31
Q2 24
$-0.26
$-0.57
Q1 24
$-0.32
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
RDI
RDI
Cash + ST InvestmentsLiquidity on hand
$61.1M
$10.5M
Total DebtLower is stronger
$185.1M
Stockholders' EquityBook value
$19.0M
$-18.2M
Total Assets
$105.6M
$434.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
RDI
RDI
Q4 25
$61.1M
$10.5M
Q3 25
$60.0M
$8.1M
Q2 25
$62.1M
$9.1M
Q1 25
$66.3M
$5.9M
Q4 24
$52.8M
$12.4M
Q3 24
$56.8M
$10.1M
Q2 24
$55.5M
$9.3M
Q1 24
$58.9M
$7.5M
Total Debt
NPCE
NPCE
RDI
RDI
Q4 25
$185.1M
Q3 25
Q2 25
Q1 25
Q4 24
$202.7M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NPCE
NPCE
RDI
RDI
Q4 25
$19.0M
$-18.2M
Q3 25
$18.5M
$-12.1M
Q2 25
$19.4M
$-7.7M
Q1 25
$24.3M
$-8.1M
Q4 24
$8.0M
$-4.4M
Q3 24
$9.8M
$1.6M
Q2 24
$9.9M
$6.5M
Q1 24
$14.3M
$18.0M
Total Assets
NPCE
NPCE
RDI
RDI
Q4 25
$105.6M
$434.9M
Q3 25
$107.3M
$435.2M
Q2 25
$106.1M
$438.1M
Q1 25
$110.2M
$441.0M
Q4 24
$94.6M
$471.0M
Q3 24
$96.3M
$495.7M
Q2 24
$94.4M
$494.9M
Q1 24
$98.9M
$494.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
RDI
RDI
Operating Cash FlowLast quarter
$506.0K
$4.3M
Free Cash FlowOCF − Capex
$409.0K
$4.1M
FCF MarginFCF / Revenue
1.5%
8.2%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$-2.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
RDI
RDI
Q4 25
$506.0K
$4.3M
Q3 25
$-1.9M
$295.0K
Q2 25
$-2.1M
$1.6M
Q1 25
$-7.5M
$-7.7M
Q4 24
$-4.8M
$8.0M
Q3 24
$-1.7M
$1.3M
Q2 24
$-3.9M
$-10.4M
Q1 24
$-7.5M
$-2.8M
Free Cash Flow
NPCE
NPCE
RDI
RDI
Q4 25
$409.0K
$4.1M
Q3 25
$-2.0M
$-246.0K
Q2 25
$-2.3M
$1.2M
Q1 25
$-7.5M
$-8.0M
Q4 24
$-4.8M
$7.0M
Q3 24
$-1.8M
$-1.1M
Q2 24
$-4.0M
$-10.6M
Q1 24
$-7.6M
$-4.7M
FCF Margin
NPCE
NPCE
RDI
RDI
Q4 25
1.5%
8.2%
Q3 25
-7.2%
-0.5%
Q2 25
-9.6%
1.9%
Q1 25
-33.4%
-19.8%
Q4 24
-22.5%
12.0%
Q3 24
-8.7%
-1.8%
Q2 24
-20.6%
-22.7%
Q1 24
-42.1%
-10.4%
Capex Intensity
NPCE
NPCE
RDI
RDI
Q4 25
0.4%
0.3%
Q3 25
0.1%
1.0%
Q2 25
0.7%
0.6%
Q1 25
0.2%
0.6%
Q4 24
0.2%
1.7%
Q3 24
0.5%
4.0%
Q2 24
0.3%
0.5%
Q1 24
0.6%
4.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPCE
NPCE

Segment breakdown not available.

RDI
RDI

Cinema Exhibition Segment$46.9M93%
Real Estate Revenue$3.4M7%

Related Comparisons